Key Takeaways
Major U.S. Investment: Eli Lilly announced a $5 billion facility in Virginia as part of a $27 billion plan to expand drug manufacturing across America over the next five years.
Policy Pressure Pays: The move follows President Trump’s call for Big...
Key Takeaways:
America-First Medicine Policy: Trump’s executive order prioritizes U.S.-made pharmaceutical ingredients to protect national security and strengthen domestic manufacturing.
Rebuilding the Reserve: The Strategic Active Pharmaceutical Ingredients Reserve (SAPIR) will be filled with a six-month supply of critical drug components, reversing Biden-era...
